Ogden Christopher sold CTMX
March 17, 2026 · Form 4 insider transaction
Ogden Christopher sold 19,323 shares of CytomX Therapeutics, Inc. at $6.42 per share, a transaction worth $124.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
19,323
Price
$6.42
Total value
$124.1K
InsiderOgden Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after296,948
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").; Includes 173,082 RSUs.